112EGP
- Active ingredient
- brivaracetam
- Strength
- 50 mg
- Form
- vial
- Manufacturer
- multi-apex
- Route
- injection
Uses
Used for treatment of partial-onset seizures in patients aged one month and older.
Do not use if
Contraindicated in patients with hypersensitivity to brivaracetam or formulation components.
Side effects
Common effects include somnolence, dizziness, fatigue, nausea, and behavioral changes.
Warnings
Monitor for suicidal thoughts, psychiatric symptoms, and excessive sedation.
How it works
Binds selectively to synaptic vesicle protein 2A (SV2A), helping reduce seizure activity.
Storage
Store at 25°C and do not freeze oral solution formulations.